News Priority review voucher prices fall again after Spark's $110... Voucher prices have fallen since their 2015 peak
News Novartis app could revolutionise ophthalmic clinical trials Patients will be able to participate in clinical ophthalmology trials from home thanks to a groundbreaking digital app developed by Novartis.
Views & Analysis Digital health round-up: Could Nokia kill off digital health... Richard Staines gives a round-up of the latest developments in digital health over the last week.
News AI predicts heart attack risk factors from retinal scans Artificial Intelligence can be used to predict heart attack risk using retinal images, according to new research backed by Google.
News FDA makes history, approving Spark's eye gene therapy Christmas has come a few days early for Spark Therapeutics after the FDA approved its ground-breaking gene therapy for a rare eye disease.
News Are Makary's priority review vouchers about to be canned? Reports are emerging that the national priority voucher scheme launched by former FDA chief Marty Makary may be heading for the scrap heap.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
